http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e294497c210f10a35b5e897e3ef0265c
Outgoing Links
Predicate | Object |
---|---|
family-name | Teruya-Feldstein |
name | Julie Teruya-Feldstein |
given-name | Julie |
organization-name | From the Medicine Branch and Laboratory of Pathology, National Cancer Institute, Bethesda, MD. 2Department of Pathology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center; Histowiz, Inc., United States. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY Authors' Affiliations: 1Division of Hematology and Oncology, 2Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center; 3Department of Pharmacology and 4Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas; Departments of 5Thoracic and Head and Neck Medical Oncology and 6Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 7Department of Pathology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York From the Hematology Service, Division of Hematologic Oncology, Department of Medicine, Sloan-Kettering Institute, and the Department of Pathology and the Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, (MSKCC) New York, NY. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY From the Lymphoma and Hematology Services of the Division of Hematological Oncology, Department of Medicine, and the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY. From the Center for Biologics Evaluation and Research, Rockville; the Laboratory of Cell Biology, National Cancer Institute, DBS, Bethesda; the Laboratory of Pathology, National Cancer Institure, DCS, Bethesda; and the Laboratory of Experimental Carcinogenesis, National Cancer Institute, DBS, Bethesda, MD. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; and Departments ofPathology Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892; Department of Hematology/Oncology, Children’s National Medical Center, Washington, DC 20010; Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21205; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD ... Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai Memorial Sloan-Kettering Cancer Center, New York, NY, USA Cancer Biology & Genetics Program 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Computational Biology Program 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Department of Medicine 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Human Oncology and Pathogenesis Program 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Genomics Core Facility 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Molecular Pharmacology Program 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Department of Pathology 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Department of Epidemiology and Biostatistics 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9; Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , and 9 From the *Center for Biologics Evaluation and Research, Rockville, Maryland 20852; and the ‡Laboratory of Cell Biology, the §Laboratory of Pathology, and the ‖Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892 Department of Pathology, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, 1275 York Avenue, New York, NY 10021, USA. From the Laboratory of Pathology, Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda; and the Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD. Department of Pathology, Icahn School of Medicine, Mount Sinai, New York, NY; Pathology, Icahn School of Medicine at Mount Sinai, New York, NY From the Departments of Pathology (Drs Pulitzer, Blochin, and Teruya-Feldstein) and Surgery (Dr Brady), Memorial Sloan-Kettering Cancer Center, New York, New York; and the Department of Pathology (Dr Amin), Montefiore Medical Center, New York, New York. From the Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD; the Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the Department of Pathology, School of Public Health, Columbia University, New York, NY. Authors' Affiliations: 1Department of Internal Medicine, Simmons Cancer Center; 2Department of Internal Medicine, Division of Hypothalamic Research; 3Department of Surgery, Hamon Center for Therapeutic Oncology Research, and 4Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas; Departments of 5Pathology, 6Thoracic/Head and Neck Medical Oncology, and 7Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Human Oncology and Pathogenesis Program and 9Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY. From the Laboratory of Clinical Investigation, Clinical Research Training Program, and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Laboratory of Pathology, National Cancer Institute, National Human Genome Research Institute, and Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland; and SAIC, Inc, Frederick, Maryland. Division of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; 11Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. From the Cell Biology Program, the Departments of Medicine, of Epidemiology and Biostatistics, and of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY. Department of Medicine 4 , 5 , and 6; Department of Pathology 4 , 5 , and 6; Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 4 , 5 , and 6 Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.; Department of Medicine and Immunology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.; Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.; Leukemia Research Fund Center at the Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, London SW3 6JB, London, UK.; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Smith Building 770A, 1 Jimmy Fund Way, Boston, MA 02115, USA From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, and Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Department of Pathology, Instituto Nacional de la Nutrición, México City, México; Institute for Pathology, GSF-Research Center for Environment and Health, Neuherberg, Germany. Department of Pathology, Department of Pathology, Memorial Sloan Kettering Cancer Center; Department of Pathology, Mount Sinai Health System, Ichan School of Medicine at Mount Sinai, New York, NY Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, From the Departments of Medicine, Radiation Oncology, Pathology, and Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY. Memorial Sloan–Kettering Cancer Center, New York, NY 10021; Laboratory of Pathology, Hematopathology Section, National Cancer Institute , Bethesda, Maryland From the Laboratory of Developmental Hematopoiesis/Cell Biology Program, the Department of Medicine, and the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; and ImClone Systems, New York, NY. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY. Department of Pathology and Radiology, Memorial Sloan-Kettering Cancer Center, New York From the Center for Biologics Evaluation and Research, Bethesda, MD; the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Hematology/Oncology, Children's National Medical Center, Washington, DC; and the Laboratory of Pathology, Hematopathology Section, National Cancer Institutes, Bethesda, MD. From the Laboratory of Pathology, Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD; the Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD; the Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the National Institute on Aging, National Institutes of Health, Baltimore, MD. 2Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York.; 3Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York. Histowiz, Long Island City, New York, United States Pathology, Memorial Sloan Kettering Cancer Center, New York, NY Pathology, 3Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, From the Departments of Medicine, Radiology, Pathology, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY. Department of Pathology 7Pathology; and Department of Pathology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; Icahn School of Medicine at Mount Sinai From the Divisions of Hematologic Products and of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration; and the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD. From the Cell Biology Program, Departments of Epidemiology and Biostatistics, Medicine, and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; the Institute for Cancer Genetics, Columbia University, New York, NY; and Cancer Genetics Inc, Milford, MA. From the Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD. |
Incoming Links
Total number of triples: 228.